Lawrence M Alleva

CIK 1553053 · last filed 2026-06-05

Lawrence M Alleva is a corporate insider who has filed 85 SEC Form 4 insider transactions across 7 companies since 2012. The most recent filing, for BFAM, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$590.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $26.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$26.57M

Companies

7

Total Filings

85

Lifetime Open-Market Net

-$590.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BFAM Director 13,336 $64.85 $864.8K -$807.4K 21 2026-06-05
Mersana Therapeutics, Inc. (MRSN) Delisted Director 0 $29.08 $0 $39.8K 25 2026-01-06
Adaptimmune Therapeutics PLC (ADAP) Delisted Director 130,764 $0.06 $7.6K $34.3K 7 2024-07-01
Galera Therapeutics, Inc. (GRTX) Delisted Director 10,370 $0.14 $1.5K $97.7K 10 2023-07-05
ASND Director 117,864 $218.06 $25.70M $39.7K 5 2019-07-03
TESARO, Inc. (TSRO) Delisted Director 0 $5.2K 13 2019-01-22
SYNLOGIC, INC. (MIRN) Delisted Director 4,025 $0 2 2016-09-06

Recent Filings

85 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 BFAM Grant (A) +2,096 $0 EDGAR
2026-01-06 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed −662 $0 EDGAR
2025-06-13 Mersana Therapeutics, Inc. (MRSN) Delisted Grant (A) $0 EDGAR
2025-06-05 BFAM Grant (A) +976 $0 EDGAR
2025-02-26 Grant (A) $0
2025-01-03 Mersana Therapeutics, Inc. (MRSN) Delisted Grant (A) $0 EDGAR
2024-10-03 Mersana Therapeutics, Inc. (MRSN) Delisted Grant (A) $0 EDGAR
2024-07-02 Mersana Therapeutics, Inc. (MRSN) Delisted Grant (A) $0 EDGAR
2024-07-01 Adaptimmune Therapeutics PLC (ADAP) Delisted Grant (A) $0 EDGAR
2024-06-12 Mersana Therapeutics, Inc. (MRSN) Delisted Grant (A) $0 EDGAR
Showing 110 of 85
Page 1 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.